The Obese Taste Bud Study
OTB
2 other identifiers
observational
210
1 country
1
Brief Summary
The sense of taste is essential for priming food preferences and is therefore important for caloric uptake and body weight regulation. Recent studies show that obesity is linked to changes in taste sensation but also to a loss of taste buds on the tongue. This study aims to evaluate underlying mechanisms within the taste buds to potentially influence the sense of taste on the level of these sensory cells and in order to develop new treatment strategies to fight obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 6, 2020
CompletedStudy Start
First participant enrolled
November 9, 2020
CompletedFirst Posted
Study publicly available on registry
November 18, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2022
CompletedJanuary 14, 2021
January 1, 2021
1.7 years
November 6, 2020
January 13, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Identification of differential gene and protein regulation in isolated human taste cells between lean and obese subjects
Transcriptomics (RNAsequencing (seq), single cell seq) and epigenomics (open chromatin mapping (ATACseq), Infinium MethylationEPIC Array) will be performed in isolated papillae fungiformes. Validation analyses by in vitro primary cell cultures of taste cell biopsy
through study completion, an average of 2 years
Identification of correlations between taste cell biology with parameters of intervention
corrleation analyses will include factors of eating behavior, food preferences, life style factors, data from taste and smell screenings, anthropometric data, blood and saliva parameters
1 year
Secondary Outcomes (2)
Differences of salivary and tongue microbiome on taste cells in obesity in contrast to lean
2 years
extracellular vesicle analyses of saliva in lean and obese subjects
2 years
Study Arms (2)
normal weight
Normal weight adults with BMI ranging from 18.5-24.9; men and women; age range 18-69years; written informed consent
obese
Subjects with obesity as defined by BMI \>= 30; men and women; age range 18-69 years; written informed consent
Interventions
Taste buds will be surgically removed a) during a planned and medically induced elective surgery under full anesthesia; b) by local anesthesia in subjects without a medically induced surgery
75g glucose will be applied in drinking water following blood sample collection to evaluate glucose, insulin and C-peptide level.
Subjects are given taste strips with 4 concentrations per each taste quality of sweet, sour, salty, bitter and umami in a pseudo-randomized manner. Subjects are asked to identify the taste quality, state the intensity, preference and certainty.
Subjects will be presented 16 different sniffing sticks in a randomized order, each for about 4seconds. People are then asked to identify the smell by choosing one out of 4 options (forced choice).
The number of taste buds on the anterior tongue will be determined by colouring the tongue surface with food colour. Taste buds will apply more reddish as compared to non-taste tissue. Based on a digital photography the number of taste buds per subjects is counted manually.
Anthropometric data collection will include measures of body height, body weight, arm-, upper- and lower leg circumferences, waist- and hip circumferences and a bioimpedance analysis to obtain data about body composition.
Blood and saliva samples will be taken as well as a tongue swab.
Through the use of several questionnaires, data about eating behavior, food preferences, life style factors and other will be obtained.
Eligibility Criteria
the study population will mainly consits of patients who underwent a medically induced elective surgery at the head or neck area (f.e. surgery at the soft palate, plastic surgery, maintenance of congenital anomalies etc.) or healthy participants recruited elsewhere at the campus area of the Medical Faculty of the University of Leipzig, Saxony, Germany.
You may qualify if:
- normal weight (BMI 18.5-24.9)
- obesity (BMI \>=30)
- overall healthy (no severe sickness, no cancer)
- written informed consent
You may not qualify if:
- current pregnancy or currently breastfeeding
- cancer or tumors
- state after radiotherapy at head-neck area
- state after or current chemotherapy
- severe psychiatric-, cardiac-, kidney- or neurological illness
- diagnosed diabetes mellitus
- known dysfunction of smelling or tasting
- drug or alcohol abuse
- permanent medication with antidepressants, anticonvulsants, steroids and/or immunosuppressants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Leipziglead
- Helmholtz Institut für Metabolismus-, Adipositas- und Gefäßforschungcollaborator
- Klinik und Poliklinik für Hals-, Nasen- und Ohrenheilkundecollaborator
- Klinik und Poliklinik für Mund-, Kiefer- und Plastische Gesichtschirurgiecollaborator
- Poliklinik für Zahnärztliche Prothetik und Werkstoffkundecollaborator
Study Sites (1)
Medical Clinic III, Division of Endocrinology, University Clinic of Leipzig
Leipzig, Saxony, 04103, Germany
Biospecimen
Taste buds, saliva, blood
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Michael Stumvoll, Prof. Dr.
Medical Faculty of the University of Leipzig, Leipzig, Germany
- PRINCIPAL INVESTIGATOR
Imke Schamarek, Dr.
Medical Faculty of the University of Leipzig, Leipzig, Germany
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinician Scientist
Study Record Dates
First Submitted
November 6, 2020
First Posted
November 18, 2020
Study Start
November 9, 2020
Primary Completion
July 15, 2022
Study Completion
July 30, 2022
Last Updated
January 14, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share
one aim of this study is to obtain large-scale sequencing data. with this several not yet defined research questions will be generated which shall be explored through later analyses and projects. in order to exploit the potential of the data and to avoid misinterpretation, the data should only be accessible to the scientists and collaborators involved.